Nykode Therapeutics ASA — Share Issue/Capital Change 2021

Nov 1, 2021

Registration of new share capital

Registration of new share capital

Reference is made to the announcement made by Vaccibody AS on September 30, 2021, regarding a share capital increase related to the exercise of employee share options. The share capital increase has now been registered with the Norwegian Register of Business Enterprises, and the company's new share capital is NOK 2,872,477.10, divided into 287,247,710 shares, each with a par value of NOK 0.01.